Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (221-230 of 263) with videos related to

Pageof 27
Sort By:
Scientific Reports|September 12, 2025
Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort studyPetar G Vuković, Aleksandra Jeremić, Milica Vezmar, et al.
Journal of Affective Disorders|February 15, 2026
Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effectsPetar G Vuković, Aleksandra Jeremić, Milica Vezmar, et al.
Clinical Pharmacology and Therapeutics|April 22, 2025
Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into AccountInger Johansson, Emmanouella M Xanthopoulou, Yitian Zhou, et al.
Cancer Causes & Control : CCC|July 9, 2003
Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States)Loïc Le Marchand, Chuanfa Guo, Simone Benhamou, et al.
Advances in Experimental Medicine and Biology|September 28, 2016
Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity TestingGlyn N Stacey, Sandra Coecke, Anna-Bal Price, et al.
Stem Cells (Dayton, Ohio)|July 18, 2015
Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem CellsDelphine Peric, Isabel Barragan, Karine Giraud-Triboult, et al.
Journal of Medicinal Chemistry|July 13, 2013
Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activityHelen M Sheldrake, Sandra Travica, Inger Johansson, et al.
Neuropathology and Applied Neurobiology|December 19, 2022
The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxiaFilip Milosavljević, Irene Brusini, Andrea Atanasov, et al.
Annual Review of Pharmacology and Toxicology|October 15, 2017
Application of Microphysiological Systems to Enhance Safety Assessment in Drug DiscoveryLorna Ewart, Eva-Maria Dehne, Kristin Fabre, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosisIsabel Cordero-Herrera, Mikael Kozyra, Zhengbing Zhuge, et al.
Pageof 27

Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
Scientific Reports|September 12, 2025
Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort studyPetar G Vuković, Aleksandra Jeremić, Milica Vezmar, et al.
Journal of Affective Disorders|February 15, 2026
Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effectsPetar G Vuković, Aleksandra Jeremić, Milica Vezmar, et al.
Clinical Pharmacology and Therapeutics|April 22, 2025
Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into AccountInger Johansson, Emmanouella M Xanthopoulou, Yitian Zhou, et al.
Cancer Causes & Control : CCC|July 9, 2003
Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States)Loïc Le Marchand, Chuanfa Guo, Simone Benhamou, et al.
Advances in Experimental Medicine and Biology|September 28, 2016
Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity TestingGlyn N Stacey, Sandra Coecke, Anna-Bal Price, et al.
Stem Cells (Dayton, Ohio)|July 18, 2015
Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem CellsDelphine Peric, Isabel Barragan, Karine Giraud-Triboult, et al.
Journal of Medicinal Chemistry|July 13, 2013
Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activityHelen M Sheldrake, Sandra Travica, Inger Johansson, et al.
Neuropathology and Applied Neurobiology|December 19, 2022
The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxiaFilip Milosavljević, Irene Brusini, Andrea Atanasov, et al.
Annual Review of Pharmacology and Toxicology|October 15, 2017
Application of Microphysiological Systems to Enhance Safety Assessment in Drug DiscoveryLorna Ewart, Eva-Maria Dehne, Kristin Fabre, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosisIsabel Cordero-Herrera, Mikael Kozyra, Zhengbing Zhuge, et al.
Pageof 27